| PERIOD ENDING | 29-Mar-09 | 31-Dec-08 | 28-Sep-08 | 29-Jun-08 | | Total Revenue | 2,439,000 | 3,288,000 | 3,693,000 | 3,887,000 | | Cost of Revenue | 1,994,000 | 2,754,000 | 2,873,000 | 3,008,000 | | | Gross Profit | 445,000 | 534,000 | 820,000 | 879,000 | | | Operating Expenses | | Research Development | 85,000 | 102,000 | 113,000 | 104,000 | | Selling General and Administrative | 298,000 | 335,000 | 393,000 | 370,000 | | Non Recurring | 66,000 | (207,000) | (3,000) | 6,000 | | Others |
-
|
-
| 136,000 | (136,000) | | | | Total Operating Expenses |
-
|
-
| 639,000 | 344,000 | | | | Operating Income or Loss | (4,000) | 304,000 | 181,000 | 535,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,000) | (248,000) | 199,000 | (66,000) | | Earnings Before Interest And Taxes | 28,000 | 56,000 | 380,000 | 469,000 | | Interest Expense | 7,000 | 9,000 | 10,000 | 12,000 | | Income Before Tax | 21,000 | 47,000 | 370,000 | 457,000 | | Income Tax Expense | 7,000 | (12,000) | 123,000 | 147,000 | | Minority Interest |
-
| (16,000) | (18,000) | (17,000) | | | | Net Income From Continuing Ops | 14,000 | 43,000 | 229,000 | 293,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,000 | 43,000 | 229,000 | 293,000 | | Preferred Stock And Other Adjustments | (7,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,000 | $43,000 | $229,000 | $293,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
